ABOUT US:

Lucence is a pioneering precision oncology company with a bold vision: a world where cancer is defeated through early detection and timely treatment. Our cutting-edge liquid biopsy tests use advanced molecular profiling to guide personalized cancer therapies, transforming how cancer is diagnosed and treated. At Lucence, we are shaping the future of precision medicine by capturing both genetic and cellular data from a single blood draw, bringing us closer to our mission of overcoming cancer.

QUALIFICATIONS

• Advanced degree (MD, PhD, or PharmD) in oncology, molecular biology, genetics, or a related field strongly preferred.
• 5–7 years’ experience in diagnostics, with a blend of Market Access, Medical Affairs, or payer engagement roles.
• Proven success in working with commercial payers to secure reimbursement for diagnostic tests.
• Deep understanding of the oncology diagnostics landscape, including NGS, MRD, MCED, and liquid biopsy applications.
• Skilled in cross-functional collaboration, scientific communication, and stakeholder engagement.
• Entrepreneurial mindset and comfort working in a fast-paced, evolving startup environment.

OTHER REQUIREMENTS

• US-based remote role with periodic travel to Palo Alto HQ, payer meetings, scientific conferences, and strategic planning sessions.
• Flexibility to work across Pacific (PST) and Singapore (SGT) time zones when needed.
• May require occasional evening or weekend calls for internal coordination or external engagements.
• Potential for full-time conversion as the company scales

ABOUT THE ROLE

We are seeking a dynamic fractional or contract-based leader to support Lucence’s US expansion across Market Access and Medical Affairs. This highly strategic and cross-functional role will drive payer engagement, clinical evidence generation, and scientific partnerships to accelerate access and adoption of our precision oncology solutions. You will be a core contributor in our mission—bringing together medical strategy, payer insights, and field engagement to support commercialization and long-term growth in the US market.